As healthcare systems around the world grapple with rising costs, growing chronic disease burdens, and increasing demand for innovative therapies, biosimil...
As biotech companies navigate increasingly complex pathways from scientific discovery to commercial success, the importance of location, expertise, and eco...
Phase I study of an AI-designed oral formulation sets a new standard in drug development Quotient Sciences announces the successful initiation of a...
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering,...
Delivers strong Q2 results and raises FY26 revenue growth, margin expansion, and non-GAAP EPS(4) guidance on continued operational momentum Second-qua...
ProBioGen announced the launch of AGE1.CR.ReX®, its next-generation avian designer cell line for stable, high-titer poxvirus production and rapi...
WFI manufacturing and other capabilities support for pharmaceutical innovation, GLP‑1 therapies, and medical devices. ILC Dover, an Ingersoll Rand bus...
The Corporate and M&A team from independent UK law firm Burges Salmon has advised PlaqueTec Limited, a Cambridge‑based medtech company pioneering int...
- Company sets ambition to achieve pipeline-led, record-high revenues by the mid-2030s - - CSP2026 is a growth strategy that will deliver profitab...
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obef...
Ebola IC50 (0.125μM)—Strong inhibition at less than half the concentration of the clinically-tested COVID-19 (0.28μM). ...
Reduced risk of disease progression or death by 63%, with median PFS of 22.2 months in the FRUSICA-2 registration study Innovent Biologics, Inc. ("I...
Head-to-Head Study Highlights Rocbrutinib as the World's First Fourth-Generation Dual Covalent and Non-Covalent BTK Inhibitor Designed to Overcome Resist...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that the Independent Data Monitoring Committee (I...
© 2026 Biopharma Boardroom. All Rights Reserved.
